FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2570-2572 June 11, 2009 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The BARI 2D Study Group PubMed Citation

The prevalence of diabetes mellitus is rising at an alarming rate and is projected to more than double by 2030.¹ The disease currently afflicts 171 million people worldwide, with 23.6 million in the United States. The adverse microvascular and macrovascular consequences of diabetes are well recognized, as is the accompanying accelerated rate of atherosclerosis that predisposes patients to coronary artery disease and to higher rates of myocardial infarction and death. Treatment strategies that are aimed at reducing these events have embraced both optimal medical therapy (lifestyle intervention, vigilant glycemic control, and aggressive secondary prevention) and interventional management (catheter-based and surgical . . . [Full Text of this Article]

Source Information

From the Department of Medicine, State University of New York at Buffalo Schools of Medicine and Public Health, Buffalo (W.E.B.); and Nuffield Department of Surgery, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom (D.P.T.).

This article (10.1056/NEJMe0904090) was published on June 7, 2009, at NEJM.org.

Related Letters:

Therapies for Type 2 Diabetes and Coronary Artery Disease
Pfisterer M. E., Zellweger M. J., Garratt K. N., Bailey S. R., Bertoldi E. G., Weinert L. S., Polanczyk C. A., DeVries J. H., Brooks M. M., Chaitman B. R., Molitch M. E., the BARI 2D Study Group , Boden W. E., Taggart D. P.
Extract | Full Text | PDF  
N Engl J Med 2009; 361:1407-1410, Oct 1, 2009. Correspondence

This article has been cited by other articles:

• Pfisterer, M. E., Zellweger, M. J., Garratt, K. N., Bailey, S. R., Bertoldi, E. G., Weinert, L. S., Polanczyk, C. A., DeVries, J. H., Brooks, M. M., Chaitman, B. R., Molitch, M. E., the BARI 2D Study Group, , Boden, W. E., Taggart, D. P. (2009). Therapies for type 2 diabetes and coronary artery disease.. NEJM 361: 1407-1408 [Full Text]  
• (2009). Treating Diabetes and Coronary Artery Disease. Journal Watch Cardiology 2009: 1-1 [Full Text]